AAN 2025: Tolebrutinib Shows Promise in Slowing Disability Progression for Secondary Progressive Multiple Sclerosis
AAN 2025: Fremanezumab Superior to Placebo in Reducing Monthly Migraine Days in Children and Adolescents
SGO 2025: The MRI Gap and How Race and Insurance Shape Cervical Cancer Treatment Timelines
Expert Insights: At APhA 2025, Pharmacists Reaffirmed Their Essential Role in Patient Care